Pharmafile Logo

COVAX

- PMLiVE

Moderna CEO makes case for firm’s lofty valuation

mRNA specialist has to convince investors after stocks slide

- PMLiVE

Moderna files record $500m IPO for RNA pipeline

Could be the largest IPO for a biotech start-up

- PMLiVE

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

A rapid round up of pharma, biotech and healthcare news

Deal Watch September 2016

Abbott, Allergan, Celgene, Moderna, Pfizer and Takeda feature in this month's pharma deals round-up

- PMLiVE

Global pledge to immunise 300 million children

Commitment made at GAVI Pledging Conference follows criticism of high vaccine prices

- PMLiVE

Pfizer’s Prevenar 13 price cut slammed by MSF

Global health charity says reduction of 20 cents is "negligible"

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links